Initial Evaluation and Workup for Syncope
The initial evaluation for syncope must include a thorough clinical history, physical examination, 12-lead ECG, and orthostatic blood pressure measurements for all patients presenting with syncope, as these are the fundamental diagnostic steps that identify the etiology in up to 50% of cases. 1
Step 1: History and Physical Examination
Key History Elements:
- Position when syncope occurred (supine, standing, sitting)
- Activity at time of event (exertion, rest, postural change)
- Presence or absence of prodromal symptoms
- Associated symptoms (palpitations, chest pain, dyspnea)
- Witness observations (duration, movements, color changes)
- Number of episodes and frequency
- Family history of sudden cardiac death or inheritable conditions
Physical Examination Focus:
- Vital signs (including orthostatic measurements)
- Cardiovascular examination (murmurs, irregular rhythm)
- Neurological examination
- Carotid sinus massage in patients >40 years without contraindications
Step 2: Initial Testing
- 12-lead ECG - Class I recommendation for all patients 1
- Orthostatic blood pressure measurements - Essential but frequently overlooked (performed in only 16% of ED evaluations) 2
- Measure supine and after standing for 3 minutes
- Positive if systolic drop ≥20 mmHg or diastolic drop ≥10 mmHg
Step 3: Risk Stratification
High-Risk Features (requiring hospitalization):
- Age >45 years
- Abnormal ECG findings
- Known structural heart disease or reduced ventricular function
- Brief or absent prodrome
- Syncope during exertion
- Syncope in supine position
- Family history of inheritable conditions or premature sudden cardiac death 1
Low-Risk Features:
- Young age
- Normal ECG
- No structural heart disease
- Long prodrome with typical vasovagal triggers
- No family history of sudden death
Step 4: Further Testing Based on Suspected Etiology
Suspected Cardiac Syncope:
- Continuous ECG monitoring (Class I, B-NR)
- Echocardiogram if structural heart disease suspected (Class IIa, B-NR)
- Electrophysiological study for suspected arrhythmic etiology (Class IIa, B-NR)
- Exercise stress testing if syncope occurs during exertion (Class IIa, C-LD) 1
Suspected Neurally Mediated Syncope:
Suspected Orthostatic Hypotension:
- Active standing test (may need extended monitoring >3 minutes for delayed orthostatic hypotension) 1, 3
Tests to Avoid Without Specific Indications:
- MRI/CT of head (Class III: No Benefit)
- Carotid artery imaging (Class III: No Benefit)
- Routine EEG (Class III: No Benefit)
- Unnecessary laboratory tests 1
Age-Specific Considerations
Pediatric/Young Adult Patients:
- Higher likelihood of neuromediated syncope (75% of pediatric cases)
- Consider conversion reactions
- Screen for primary arrhythmic causes (long QT, WPW syndrome)
- By age 18, approximately 30-50% of children experience at least one fainting episode 1
Middle-Aged Patients:
- Higher likelihood of neuromediated syncope 1
Older Adults:
- Higher likelihood of cardiac output obstruction (aortic stenosis, pulmonary embolism)
- Higher likelihood of arrhythmias from underlying cardiac disease
- More likely to have orthostatic hypotension or carotid sinus hypersensitivity 1, 4
Common Pitfalls to Avoid
Dismissing cardiac causes when initial ECG is normal - Intermittent arrhythmias may require extended monitoring 1
Assuming orthostatic hypotension is ruled out by a single negative test - Delayed orthostatic hypotension may take >3 minutes to develop 1, 2
Focusing on neurological causes before excluding cardiac etiologies - Cardiac causes are more life-threatening and should be ruled out first 1
Overlooking orthostatic blood pressure measurements - Despite being recommended in guidelines, OBPM is performed in only 16% of ED evaluations 2
Treating presyncope differently from syncope - Patients with presyncope have similar prognoses and should undergo similar evaluation 5
Remember that cardiac syncope is associated with higher mortality (18-33% at 1 year) compared to non-cardiac causes (3-4%), making proper identification of etiology crucial for patient outcomes 1.